Publications by authors named "Kate Oliver"

Claim this Profile
S
Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study.
Justine Yang Bruce, Adam Burr, Randall J Kimple, David P Adam, Menggang Yu, Kate Oliver

EBioMedicine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy.
Jarrod Longcor, Natalie Callander, Kate Oliver, Asher Chanan-Khan, Sikander Ailawadhi

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Kate E Oliver, William E Brady, Michael Birrer, David M Gershenson, Gini Fleming

Gynecol Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.
Pang-Ning Teng, Nicholas W Bateman, Guisong Wang, Tracy Litzi, Brian E Blanton, Kate E Oliver

Hum Cell· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: a Surveillance, Epidemiology and End Results study.
William J Lowery, Michael P Stany, Neil T Phippen, Kristen P Bunch, Kate E Oliver

Gynecol Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer and antiangiogenic therapy: caveat emptor.
Kate E Oliver, William P McGuire

J Clin Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK1/2 inhibitors in the treatment of gynecologic malignancies.
Caela R Miller, Kate E Oliver, John H Farley

Gynecol Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovation in hospital quality improvement activities--acute postoperative pain management (APOP) self-help toolkit audits as an example.
Lisa K Pulver, Kate Oliver, Susan E Tett

J Healthc Qual· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous Resolution of Mirror Syndrome following Demise of Hydropic Twin.
Kate E Oliver, Kimberly W Hickey, Scott M Petersen

Case Rep Obstet Gynecol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of a sample preparation and analytical workflow for proteomics of archival endometrial cancer tissue.
Addie Alkhas, Brian L Hood, Kate Oliver, Pang-Ning Teng, Julie Oliver

J Proteome Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment.
Kate E Oliver, Lindsey R Enewold, Kangmin Zhu, Thomas P Conrads, G Scott Rose

Gynecol Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering surveillance, epidemiology, and end results data analysis: are we seeing the whole picture?
Kate E Oliver, John H Farley

Cancer· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors.
William Schelman, Sherry Morgan-Meadows, Howard Bailey, Kyle Holen, James P Thomas, Kate Oliver

Cancer Chemother Pharmacol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial.
Mathew J Summers, Kate R Oliver, Jeff S Coombes, Robert G Fassett

Pharmacotherapy· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OR expansion--a journey into the unknown.
Kate L Oliver

AORN J· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis